ClinicalTrials.gg
RecruitingNCT06401993Updated Dec 3, 2024

Peripheral-central Correlation Study on the Treatment of Chronic Tinnitus With "Dao qi Tong Luo" Based on the Theory of "Connecting the Two Ears to the Brain"

An interventional study of The "dao qi tong luo" group and The acupuncture group in Tinnitus, sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University. Recruiting at 1 site in China. Open to participants aged 20 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-03.

Sponsored by The Third Affiliated hospital of Zhejiang Chinese Medical University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as recruiting.
  • Started May 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
87
Allocation
Randomized
Ages
20 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 32 studies in Tinnitus with a site in China — 18 open to participants now, 18 under way, none of them phase 3. Tinnitus · China.

Planned enrollment
19th of 27
87 · median 120
Started
2024
with 5 others
No phase
27 of 32
16 open now
Primary completion
2026-08
later than 6 of 17 live
Registered
18th of 32
by date
Lead sponsor
3 of 32
The Third Affiliated hospital of Zhejiang Chinese Medical University

Among the 32 studies in Tinnitus with a site in China, this one is the 19th largest by planned enrollment of the 27 interventional ones that give a count, is one of 6 that started in 2024, is one of 27 with no phase, reaches primary completion later than 6 of the 17 other live ones, and was the 18th registered.

Tinnitus

446 studies on the registry are indexed under Tinnitus; 98 are open to participants now.

Browse Tinnitus studies →

Open to participants now

18 of the 32 studies in Tinnitus with a site in China are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 49 Tinnitus studies recruiting now, 21 (43%) set no upper age limit and 18 (37%) stop at 75 or younger; 4 take children under 18; 10 take healthy volunteers.

This study: 20 Years to 55 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 32 studies in Tinnitus with a site in China, or all of them as a file.
02

Study summary

By comparing the clinical manifestations, ABR parameters and cerebral cortex blood oxygen levels of chronic tinnitus patients and healthy subjects under two different body states, the peripheral-central correlation of chronic tinnitus patients was explored, and the modern scientific significance of the theory of "two ears connecting the brain" was initially expounded. On this basis, the immediate and cumulative effects and peripheral-central correlation of "dao qi tong luo" intervention in chronic tinnitus were observed, and the effective mechanism of "dao qi tong luo" treatment was explored.

Read the detailed description

The study will enroll 15 healthy subjects and 72 subjects with chronic tinnitus. Functional near infrared spectroscopy (fNIRS) will be used to examine specific brain regions, and ABR techniques will record auditory brainstem responses in chronic tinnitus patients and healthy subjects. Lateral comparison was made between chronic tinnitus patients and healthy subjects on the parameters of auditory brainstem response and the level of oxygen outside the cerebral cortex, and the data of the two were integrated to conduct correlation analysis and correlation analysis with clinical manifestations, so as to compare the correlation between peripheral and central auditory function in different body states. Subsequently, the chronic tinnitus subjects will undergo a course of acupuncture treatment. At the end of acupuncture and moxibustion treatment, the immediate and cumulative effects and peripheral - central correlation of "dao qi tong luo" intervention in chronic tinnitus were observed, and the effective mechanism of "dao qi tong luo" treatment was explored.

03

Conditions studied

  • Tinnitus

Browse trials for

Keywords

  • Acupuncture
  • Fnirs
  • Tinnitus
  • ABR
04

Who can participate

Ages eligible
20 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Inclusion criteria for patients with chronic tinnitus

    1. Chronic tinnitus patients, that is, the course of disease ≥6 months;
    2. No of fNIRS scanning;
    3. The age of 20 years ≤55 years old, gender is not limited, right-handed;
    4. The external ear canal is unobstructed and the eardrum is intact
    5. The average hearing threshold of both ears is \<35dB;
    6. Normal expression and understanding ability. Inclusion criteria for healthy subjects

    <!-- -->

    1. No tinnitus, no hearing disorders and other ear diseases;
    2. Good health condition, no history of mental disease and nervous system disease;
    3. No contraindications of fNIRS scanning;
    4. The age of 20 years ≤55 years old, gender is not limited, right-handed;
    5. The external ear canal is unobstructed, and the tympanic membrane is complete;
    6. Normal expression and understanding ability.

Exclusion criteria

Exclusion Criteria:

  • 1.A history of drug dependence or alcohol addiction; 2.Serious central system diseases or other systemic diseases such as cardiovascular and cerebrovascular diseases; 3. Patients with organic diseases such as craniocerebral trauma; 4. Sudden deafness, Meniere's disease, otosclerosis, acoustic neuroma and other inner ear or auditory nerve diseases; 5.External otitis, acute/chronic otitis media and other external ear middle-ear related diseases; 6. Patients with auditory ; 7. Pregnancy, preparation for pregnancy, breastfeeding population; 8. There are metal implants in the body, fNIRS detection .
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
87 participants (estimated)

Study arms

  • Experimental
    The "dao qi tong luo" group

    Subjects in the "dao qi tong luo" group will undergo acupuncture treatment, which is administered 10 times

    Procedure: The "dao qi tong luo" group

  • Sham comparator
    The acupuncture group

    Subjects in the acupuncture group will undergo acupuncture treatment, which is administered 10 times

    Procedure: The acupuncture group

Interventions

  • ProcedureThe "dao qi tong luo" group

    The "dao qi tong luo" group will accept acpuncture. Acupuncture will be performed at acupoints including TE17 (Yifeng), SI19 (Tinggong), GB2 (Tinghui), TE5 (Waiguan), TE3 (Zhongzhu) and etc. Among them, the "dao qi tong luo" group will make patients feel qi.

  • ProcedureThe acupuncture group

    The acupuncture group will accept acpuncture. Acupuncture will be performed at acupoints including TE17 (Yifeng), SI19 (Tinggong), GB2 (Tinghui), TE5 (Waiguan), TE3 (Zhongzhu) and etc. The acupuncture group will not feel qi.

06

What researchers measure

Primary outcomes

  1. Tinnitus Handicap Inventory (THI)

    Tinnitus Handicap Inventory is based on relevant expert consensus. THI scores range from 0 to 100, with the higher the score, the more severe the condition

    Time frame: at baseline (pre-treatment),procedure

Secondary outcomes

  1. Tinnitus Evaluation Questionnaire (TEQ)

    Tinnitus Evaluation Questionnaire is based on relevant expert consensus. TEQ scores range from 0 to 21, with the higher the score, the more severe the condition

    Time frame: at baseline (pre-treatment), procedure

  2. Auditory Brainstem Response (ABR)

    Auditory Brainstem Response is based on relevant expert consensus

    Time frame: at baseline (pre-treatment), procedure

  3. Functional Near-Infrared Spectroscopy (Fnirs)

    Functional Near-Infrared Spectroscopy is based on relevant expert consensus

    Time frame: at baseline (pre-treatment), procedure

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Aug 2026, 27 months after the start.

Of 134 non-industry interventional studies with no phase under Tinnitus, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 27 months is above that.

Counting every sponsor, half of 153 studies reached it within 17 months; a quarter within 10 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2024
First posted
May 7, 2024
StartActual
May 4, 2024
Primary completionEst.
Aug 2026
CompletionEst.
Dec 2026
Last update
Dec 3, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 3, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06401993
Lead sponsor
The Third Affiliated hospital of Zhejiang Chinese Medical University
Responsible party
Jie Zhou (Principal Investigator, The Third Affiliated hospital of Zhejiang Chinese Medical University) — Principal investigator
First posted
May 7, 2024
Start date
May 4, 2024
Primary completion
Aug 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Dec 3, 2024

Study contacts

Da Jiang, M.M
Contact
jddyx2023@163.com
18890261521
Jie Zhou, M.D
principal investigator · The Third Affiliated hospital of Zhejiang Chinese Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion